文献
J-GLOBAL ID:201802222706887771
整理番号:18A0279882
Ω-3酸エチルエステル製剤の生物学的同等性証明:現在の誘導の修飾のための理論的根拠【Powered by NICT】
Bioequivalence Demonstration for Ω-3 Acid Ethyl Ester Formulations: Rationale for Modification of Current Guidance
著者 (10件):
Maki Kevin C.
(Midwest Biomedical Research/Center for Metabolic and Cardiovascular Research and Department of Food Science and Nutrition, Illinois Institute of Technology, Chicago, Illinois)
,
Johns Colleen
(Sancilio and Company, Inc, Riviera Beach, Florida)
,
Harris William S.
(Sanford School of Medicine, University of South Dakota, Sioux Falls, South Dakota)
,
Harris William S.
(OmegaQuant Analytics, LLC, Sioux Falls, South Dakota)
,
Puder Mark
(Vascular Biology Program and Department of Surgery, Boston Children’s Hospital, Boston, Massachusetts)
,
Freedman Steven D.
(Division of Translational Research and Gastroenterology, Beth Israel Deaconess Medical Center, Boston, Massachusetts)
,
Thorsteinsson Thorsteinn
(Sancilio and Company, Inc, Riviera Beach, Florida)
,
Daak Ahmed
(Sancilio and Company, Inc, Riviera Beach, Florida)
,
Rabinowicz Adrian L.
(Sancilio and Company, Inc, Riviera Beach, Florida)
,
Sancilio Frederick D.
(Sancilio and Company, Inc, Riviera Beach, Florida)
資料名:
Clinical Therapeutics
(Clinical Therapeutics)
巻:
39
号:
3
ページ:
652-658
発行年:
2017年
JST資料番号:
A1157A
ISSN:
0149-2918
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)